Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, China Health Group's Enterprise Value is HK$50.26 Mil.
China Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.86 Mil. Therefore, China Health Group's EV-to-EBIT ratio for today is -2.98.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, China Health Group's Enterprise Value is HK$50.26 Mil.
China Health Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.86 Mil. Therefore, China Health Group's EV-to-EBITDA ratio for today is -2.98.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, China Health Group's Enterprise Value is HK$50.26 Mil.
China Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$31.30 Mil. Therefore, China Health Group's EV-to-Revenue ratio for today is 1.61.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
China Health Group (HKSE:08225) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. China Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.86 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. China Health Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.86 Mil.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$31.30 Mil.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$8.27 Mil.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$8.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group Enterprise Value Related Terms
China Health Group Enterprise Value Historical Data
* Premium members only.
The historical data trend for China Health Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08225 vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, China Health Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where China Health Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
China Health Group's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$50.26 Mil mean?
China Health Group (HKSE:08225) has a Enterprise Value of HK$50.26 Mil as of Aug. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on China Health Group and its competitors.
Is China Health Group's Enterprise Value too high?
China Health Group's current Enterprise Value is HK$50.26 Mil.
How does China Health Group's Enterprise Value compare to TMO and DHR?
China Health Group's Enterprise Value of HK$50.26 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on China Health Group and its competitors. China Health Group's current Enterprise Value is HK$50.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:08225) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.21, compared to a current price of HK$0.08 — trading 61.4% below its estimated fair value. The current Enterprise Value is HK$50.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For China Health Group (HKSE:08225), the current Enterprise Value is HK$50.26 Mil as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of its revenue for the company comes from the provision of PM services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08225 has been successfully added to your 
